ATE275977T1 - Kamm-polymere zur regelung der zelloberflächenwechselwirkung - Google Patents

Kamm-polymere zur regelung der zelloberflächenwechselwirkung

Info

Publication number
ATE275977T1
ATE275977T1 AT99917442T AT99917442T ATE275977T1 AT E275977 T1 ATE275977 T1 AT E275977T1 AT 99917442 T AT99917442 T AT 99917442T AT 99917442 T AT99917442 T AT 99917442T AT E275977 T1 ATE275977 T1 AT E275977T1
Authority
AT
Austria
Prior art keywords
comb
combs
cellular response
cell
hydrophilic
Prior art date
Application number
AT99917442T
Other languages
English (en)
Inventor
Anne M Mayes
Linda G Griffith
Darrell J Irvine
Pallab Banerjee
Terry D Johnson
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Application granted granted Critical
Publication of ATE275977T1 publication Critical patent/ATE275977T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/641—Branched, dendritic or hypercomb peptides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G81/00—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G81/00—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
    • C08G81/02—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers at least one of the polymers being obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • C08G81/024—Block or graft polymers containing sequences of polymers of C08C or C08F and of polymers of C08G

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Paints Or Removers (AREA)
AT99917442T 1998-04-13 1999-04-13 Kamm-polymere zur regelung der zelloberflächenwechselwirkung ATE275977T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8159698P 1998-04-13 1998-04-13
PCT/US1999/008031 WO1999052560A1 (en) 1998-04-13 1999-04-13 Comb copolymers for regulating cell-surface interactions

Publications (1)

Publication Number Publication Date
ATE275977T1 true ATE275977T1 (de) 2004-10-15

Family

ID=22165144

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99917442T ATE275977T1 (de) 1998-04-13 1999-04-13 Kamm-polymere zur regelung der zelloberflächenwechselwirkung

Country Status (8)

Country Link
US (3) US6150459A (de)
EP (1) EP1071467B1 (de)
JP (1) JP2002511496A (de)
AT (1) ATE275977T1 (de)
AU (1) AU752942B2 (de)
CA (1) CA2328436C (de)
DE (1) DE69920198T2 (de)
WO (1) WO1999052560A1 (de)

Families Citing this family (148)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE400352T1 (de) 1996-08-26 2008-07-15 Massachusetts Inst Technology Herstellung von polymergegenständen mit hydrophiler oberfläche
US20030198825A1 (en) * 1996-08-26 2003-10-23 Massachusetts Institute Of Technology Polymeric membranes and other polymer articles having desired surface characteristics and method for their preparation
JP2002511179A (ja) 1996-10-11 2002-04-09 マサチューセッツ・インスティテュート・オブ・テクノロジー 電池のための固体電解質、インターカレーション化合物及び電極
JP2002515932A (ja) * 1997-04-18 2002-05-28 カリフォルニア インスティチュート オブ テクノロジー 多機能性ポリマー性組織コーティング
US6893877B2 (en) 1998-01-12 2005-05-17 Massachusetts Institute Of Technology Methods for screening substances in a microwell array
DE69920198T2 (de) 1998-04-13 2005-09-22 Massachusetts Institute Of Technology, Cambridge Kamm-polymere zur regelung der zelloberflächenwechselwirkung
US6541022B1 (en) * 1999-03-19 2003-04-01 The Regents Of The University Of Michigan Mineral and cellular patterning on biomaterial surfaces
US6767928B1 (en) 1999-03-19 2004-07-27 The Regents Of The University Of Michigan Mineralization and biological modification of biomaterial surfaces
AU756982B2 (en) 1999-03-19 2003-01-30 Life Technologies Corporation Multi-through hole testing plate for high throughput screening
US7083777B1 (en) * 1999-04-02 2006-08-01 The Brigham And Women's Hospital, Inc. Immunomodulating polymers
DE60041255D1 (de) * 1999-04-28 2009-02-12 Eidgenoess Tech Hochschule Polyionische beschichtungen für analytische und sensor-vorrichtungen
WO2001060912A2 (en) 2000-02-17 2001-08-23 Massachusetts Institute Of Technology Pressure processable polymer compositions
US20020151040A1 (en) 2000-02-18 2002-10-17 Matthew O' Keefe Apparatus and methods for parallel processing of microvolume liquid reactions
WO2001061054A2 (en) 2000-02-18 2001-08-23 Board Of Trustees Of The Leland Stanford Junior University Apparatus and methods for parallel processing of micro-volume liquid reactions
US7163712B2 (en) 2000-03-03 2007-01-16 Duke University Microstamping activated polymer surfaces
ATE466042T1 (de) * 2000-03-08 2010-05-15 Lab Internat Barbados Srl Kolloidale nanopartikuläre träger enthaltend geladene oder ungeladene wasserlösliche kammpolymere und deren verwendung zur mucosalen applikation
US6616944B2 (en) * 2000-03-08 2003-09-09 Medinnova Gesellschaft Fur Medizinsche Innovationen Aus Adkademischer Forschung Mbh Self-assembling colloidal carriers for protein delivery
EP1142596A1 (de) * 2000-04-03 2001-10-10 Universiteit Gent Zusammensetzung von vernetzbaren Prepolymeren zum Gebrauch in therapeutisch aktiven, bioabbaubaren Implantaten
KR100433614B1 (ko) * 2000-06-16 2004-05-31 주식회사 태평양 친수성 또는 염의 형태로 된 약물을 함유하는 경피흡수제제
DE10036907B4 (de) * 2000-07-28 2012-03-22 Xantec Bioanalytics Gmbh Verfahren zur Herstellung einer Beschichtung auf einem mit Gold bedampften Glassubstrat, Beschichtung hergestellt nach diesem Verfahren und deren Verwendung
CN1469892A (zh) 2000-09-11 2004-01-21 ��ʡ��ѧԺ 接枝共聚物,将亲水链接枝到疏水聚合物上的方法,及其制品
US6649138B2 (en) * 2000-10-13 2003-11-18 Quantum Dot Corporation Surface-modified semiconductive and metallic nanoparticles having enhanced dispersibility in aqueous media
SV2003000753A (es) 2000-12-05 2003-06-16 Brigham & Womens Hospital Uso de polisacaridos zwitterionicos para la especifica modulacion del progreso inmunologico
AUPR259301A0 (en) * 2001-01-18 2001-02-15 Polymerat Pty Ltd Polymers having co-continuous architecture
DE10104991A1 (de) * 2001-02-03 2002-08-08 Clariant Gmbh Mikroverkapselte biologisch aktive Wirkstoffe enthaltend ein wasserlösliches oder wasserdispergierbares Kammpolymer
US20050177237A1 (en) * 2001-04-12 2005-08-11 Ben Shappley Spinal cage insert, filler piece and method of manufacturing
WO2002083194A1 (en) 2001-04-12 2002-10-24 Therics, Inc. Method and apparatus for engineered regenerative biostructures
US7524513B2 (en) * 2001-06-15 2009-04-28 Mao Hai-Quan Biofunctional fibers
JP3515570B2 (ja) * 2001-07-31 2004-04-05 三菱レイヨン株式会社 内壁部に櫛形ポリマーが導入された中空繊維、ゲル充填中空繊維及び繊維配列体薄片
GB0130608D0 (en) * 2001-12-21 2002-02-06 Psimedica Ltd Medical fibres and fabrics
US20030215626A1 (en) * 2002-03-22 2003-11-20 Hiller Jeri?Apos;Ann Nanoporous coatings
US20060199260A1 (en) * 2002-05-01 2006-09-07 Zhiyu Zhang Microbioreactor for continuous cell culture
CA2483661A1 (en) * 2002-05-03 2003-11-13 Pall Corporation Blended polymer membrane media for treating aqueous fluids
EP1534755B1 (de) 2002-05-10 2011-10-12 Bio-Layer Pty Limited Erzeugung von oberflächenbeschichtungsdivergenz
AU2003258986A1 (en) * 2002-07-05 2004-01-23 Massachusetts Institute Of Technology Graft copolymers
US20040226620A1 (en) * 2002-09-26 2004-11-18 Daniel Therriault Microcapillary networks
US7053125B2 (en) * 2002-11-14 2006-05-30 The Board Of Trustees Of The University Of Illinois Controlled dispersion of colloidal suspension by comb polymers
US6761651B2 (en) * 2002-11-22 2004-07-13 Chin-Dong Pai Aluminum tennis racket
US20040121339A1 (en) * 2002-12-19 2004-06-24 Jizhong Zhou Special film-coated substrate for bio-microarray fabrication and use thereof
AU2003302264A1 (en) 2002-12-20 2004-09-09 Biotrove, Inc. Assay apparatus and method using microfluidic arrays
US20040127818A1 (en) * 2002-12-27 2004-07-01 Roe Steven N. Precision depth control lancing tip
WO2004063271A2 (en) * 2003-01-07 2004-07-29 Massachusetts Institute Of Technology Structured baroplastic materials
US6982298B2 (en) * 2003-01-10 2006-01-03 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US8138265B2 (en) * 2003-01-10 2012-03-20 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US8137688B2 (en) * 2003-01-10 2012-03-20 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US7465766B2 (en) * 2004-01-08 2008-12-16 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
WO2004089407A2 (en) 2003-03-31 2004-10-21 The Brigham And Women's Hospital, Inc. Zwitterionic immunomodulators for the treatment of asthma and allergy
US20050014670A1 (en) * 2003-05-20 2005-01-20 Arch Uk Biocides Composition and use
US7141617B2 (en) * 2003-06-17 2006-11-28 The Board Of Trustees Of The University Of Illinois Directed assembly of three-dimensional structures with micron-scale features
US7157275B2 (en) * 2003-08-15 2007-01-02 Becton, Dickinson And Company Peptides for enhanced cell attachment and growth
US20050063937A1 (en) * 2003-09-16 2005-03-24 Cheng Li Multiple-arm peptide compounds, methods of manufacture and use in therapy
US20050085922A1 (en) * 2003-10-17 2005-04-21 Shappley Ben R. Shaped filler for implantation into a bone void and methods of manufacture and use thereof
AU2004296412B2 (en) * 2003-12-12 2011-03-10 Anteo Technologies Pty Ltd A method for designing surfaces
EP1735097B1 (de) 2004-03-12 2016-11-30 Life Technologies Corporation Ladung eines nanoliter-arrays
US9498563B2 (en) 2004-04-23 2016-11-22 Boston Scientific Scimed, Inc. Medical articles having therapeutic-agent-containing regions formed from coalesced polymer particles
US7446131B1 (en) 2004-06-10 2008-11-04 The United States Of America As Represented By The Secretary Of Agriculture Porous polymeric matrices made of natural polymers and synthetic polymers and optionally at least one cation and methods of making
US7285595B2 (en) * 2004-06-30 2007-10-23 Kimberly-Clark Worldwide, Inc. Synergistic fluorochemical treatment blend
US20060003154A1 (en) * 2004-06-30 2006-01-05 Snowden Hue S Extruded thermoplastic articles with enhanced surface segregation of internal melt additive
WO2006002472A1 (en) 2004-07-02 2006-01-12 Bio-Layer Pty Ltd Use of metal complexes
US7713539B2 (en) * 2004-07-19 2010-05-11 Boston Scientific Scimed, Inc. Medical devices containing radiation resistant block copolymer
US20060105453A1 (en) 2004-09-09 2006-05-18 Brenan Colin J Coating process for microfluidic sample arrays
US12070731B2 (en) 2004-08-04 2024-08-27 Life Technologies Corporation Methods and systems for aligning dispensing arrays with microfluidic sample arrays
WO2006037022A2 (en) * 2004-09-24 2006-04-06 Massachusetts Institute Of Technology Microbioreactor for continuous cell culture
JP2006087396A (ja) * 2004-09-27 2006-04-06 National Institute For Environmental Studies 細胞培養基質及びその製造方法
US20060088571A1 (en) * 2004-10-21 2006-04-27 Medtronic Vascular, Inc. Biocompatible and hemocompatible polymer compositions
EP1754731A1 (de) * 2005-08-16 2007-02-21 Nederlandse Organisatie voor Toegepast-Natuuurwetenschappelijk Onderzoek TNO Verfahren zur Veränderung von Materialoberflächen
DE102005047786A1 (de) * 2005-10-05 2007-04-19 Urs Isler Verfahren zur Behandlung von Gamen zur Authentifizierung und Vorrichtung zum Nachweis der Authentizität
US20090306342A1 (en) * 2005-12-30 2009-12-10 Bio-Layer Pty Limited Binding of molecules
AU2006336311B2 (en) 2006-01-19 2013-01-24 Allexcel, Inc. Solubilization and targeted delivery of drugs with self-assembling amphiphilic polymers
US8206726B2 (en) 2006-02-06 2012-06-26 The Brigham And Women's Hospital, Inc. Zwitterionic polysaccharides for promotion of immune system maturation and health
US20070254006A1 (en) * 2006-02-15 2007-11-01 Massachusetts Institute Of Technology Medical Devices and Coatings with Non-Leaching Antimicrobial Peptides
US8545865B2 (en) * 2006-03-24 2013-10-01 Boston Scientific Scimed, Inc. Medical devices having polymer brushes
US8505745B2 (en) 2006-04-11 2013-08-13 Massachusetts Institute Of Technology Fouling resistant membranes formed with polyacrylonitrile graft copolymers
US8092818B2 (en) 2006-05-17 2012-01-10 Boston Scientific Scimed, Inc. Medical devices having bioactive surfaces
EP2682456A3 (de) * 2006-05-24 2014-03-05 Agency for Science, Technology and Research Bioaktive Oberfläche
DE102006060340B4 (de) * 2006-12-13 2012-12-13 Leibniz-Institut Für Polymerforschung Dresden E.V. Verwendung einer dauerhaften Beschichtung von Metall- oder Glasoberflächen zurBe- und/oder Verhinderung des Vereisens
FI119513B (fi) * 2007-03-07 2008-12-15 Dextech Medical Ab Muokatut hydroksipolymeerikonjugaatit, joilla on tappava vaikutus tuumorisoluihin
US7956102B2 (en) 2007-04-09 2011-06-07 The Board Of Trustees Of The University Of Illinois Sol-gel inks
US8093039B2 (en) * 2007-04-10 2012-01-10 The Trustees Of The Stevens Institute Of Technology Surfaces differentially adhesive to eukaryotic cells and non-eukaryotic cells
CN105561324A (zh) * 2007-07-19 2016-05-11 阿列克斯塞尔公司 作为抗癌剂的自组装的两亲性聚合物
DE102007049013A1 (de) * 2007-10-11 2009-04-16 Endress + Hauser Conducta Gesellschaft für Mess- und Regeltechnik mbH + Co. KG Sensor mit Langzeitstabilität für Bio-Prozesse
US20090149673A1 (en) * 2007-12-05 2009-06-11 Semprus Biosciences Corp. Synthetic non-fouling amino acids
US20090155335A1 (en) * 2007-12-05 2009-06-18 Semprus Biosciences Corp. Non-leaching non-fouling antimicrobial coatings
EP2249891B1 (de) 2008-02-13 2016-05-25 The Cleveland Clinic Foundation Molekulare verstärkung von extrazellulärer matrix und anwendungsverfahren
US8410180B2 (en) * 2008-04-30 2013-04-02 The Cleveland Clinic Foundation Methods to treat urinary incontinence
EP2294118B1 (de) 2008-05-30 2012-07-04 3M Innovative Properties Company Verfahren zur herstellung von ligandenfunktionalisierten substraten
JP2011523965A (ja) * 2008-05-30 2011-08-25 スリーエム イノベイティブ プロパティズ カンパニー リガンド官能化基材
CN101684174B (zh) * 2008-07-09 2012-04-25 天津大学 两亲性可生物降解聚酯梳型接枝共聚物及其温敏原位凝胶体系
WO2010033807A1 (en) * 2008-09-19 2010-03-25 3M Innovative Properties Company Ligand graft functionalized substrates
US7922939B2 (en) 2008-10-03 2011-04-12 The Board Of Trustees Of The University Of Illinois Metal nanoparticle inks
US8187500B2 (en) 2008-10-17 2012-05-29 The Board Of Trustees Of The University Of Illinois Biphasic inks
WO2010065960A2 (en) * 2008-12-05 2010-06-10 Semprus Biosciences Corp. Non-fouling, anti-microbial, anti-thrombogenic graft-from compositions
EP2352796A1 (de) 2008-12-05 2011-08-10 Semprus Biociences Corporation Schichtförmige überzüge mit antifouling-, antimikrobiellen und antithrombogenen eigenschaften
US8497356B2 (en) 2009-02-17 2013-07-30 Duke University Biomolecule polymer conjugates and methods for making the same
CN101530753B (zh) * 2009-03-30 2011-11-30 浙江大学 Peg接枝的聚砜或聚醚砜中空纤维膜及其制备方法与用途
US9295760B2 (en) 2009-04-09 2016-03-29 The University Of Queensland Block copolymer blends
WO2011156596A2 (en) 2010-06-09 2011-12-15 Semprus Biosciences Corp. Articles having non-fouling surfaces and processes for preparing the same including pretreatment of substrates
CA2799786A1 (en) 2010-06-09 2011-12-15 Semprus Biosciences Corp. Non-fouling, anti-microbial, anti-thrombogenic graft compositions
AU2011264834B2 (en) 2010-06-09 2015-03-12 Semprus Biosciences Corp. Non-fouling, anti-microbial, anti-thrombogenic graft-from compositions
ES2571735T3 (es) * 2010-10-20 2016-05-26 Dsm Ip Assets Bv Composiciones biodegradables que soportan grupo hidrófilo colgante y dispositivos relacionados
MY161859A (en) 2011-01-03 2017-05-15 Avm Biotechnology Llc Personalized production of biologics and method for reprogramming somatic cells
AU2012256403B2 (en) 2011-03-17 2016-10-20 Corning Incorporated Synthetic coating for cell culture
US8487017B2 (en) 2011-06-27 2013-07-16 Covidien Lp Biodegradable materials for orthopedic devices based on polymer stereocomplexes
US9539281B2 (en) 2011-07-12 2017-01-10 The Brigham And Women's Hospital, Inc. Lipid-containing PSA compositions, methods of isolation and methods of use thereof
US8414654B1 (en) * 2011-11-23 2013-04-09 Amendia, Inc. Bone implants and method of manufacture
TWI487543B (zh) * 2011-12-12 2015-06-11 Ind Tech Res Inst 梳狀結構高分子、醫療裝置的改質方法及醫療裝置
US9120119B2 (en) 2011-12-14 2015-09-01 Semprus Biosciences Corporation Redox processes for contact lens modification
CA2859195C (en) 2011-12-14 2016-09-27 Semprus Biosciences Corp. Imbibing process for contact lens surface modification
US9000063B2 (en) 2011-12-14 2015-04-07 Semprus Biosciences Corporation Multistep UV process to create surface modified contact lenses
CA2858730C (en) 2011-12-14 2017-07-18 Semprus Biosciences Corp. Surface modified contact lenses
WO2013090790A1 (en) 2011-12-14 2013-06-20 Semprus Biosciences Corp. Silicone hydrogel contact lens modified using lanthanide or transition metal oxidants
US9480747B2 (en) 2012-01-24 2016-11-01 Bvw Holding Ag Class of anti-adhesion hydrogels with healing aspects
BR112014019157B1 (pt) 2012-02-02 2022-02-22 Corning Incorporated Meio de ligação sintético para cultura de célula
WO2014070769A1 (en) 2012-10-29 2014-05-08 The University Of North Carolina At Chapel Hill Methods and compositions for treating mucosal tissue disorders
FR3003764B1 (fr) * 2013-03-27 2015-05-01 Maco Pharma Sa Unite de filtration des leucocytes a adhesion des plaquettes reduite
WO2014194244A1 (en) 2013-05-30 2014-12-04 Duke University Enzyme-catalyzed synthesis of site-specific and stoichiometric biomolecule-polymer conjugates
US10364451B2 (en) 2013-05-30 2019-07-30 Duke University Polymer conjugates having reduced antigenicity and methods of using the same
US10392611B2 (en) 2013-05-30 2019-08-27 Duke University Polymer conjugates having reduced antigenicity and methods of using the same
US9228044B2 (en) 2014-04-02 2016-01-05 International Business Machines Corporation Versatile, facile and scalable route to polylactic acid-backbone graft and bottlebrush copolymers
US9458268B2 (en) 2014-04-02 2016-10-04 International Business Machines Corporation Lactide-functionalized polymer
US9505858B2 (en) 2014-10-21 2016-11-29 International Business Machines Corporation Polylactic acid (PLA) with low moisture vapor transmission rates by grafting through of hydrophobic polymers directly to PLA backbone
US9187597B1 (en) 2014-10-21 2015-11-17 International Business Machines Corporation Flame-retardant polylactic acid (PLA) by grafting through of phosphorus-containing polymers directly to PLA backbone
US9193818B1 (en) 2014-10-29 2015-11-24 International Business Machines Corporation Toughened polylactic acid (PLA) by grafting through of impact-modifying polymers directly to PLA backbone
US10385115B2 (en) 2015-03-26 2019-08-20 Duke University Fibronectin type III domain-based fusion proteins
EA037478B1 (ru) 2015-08-04 2021-04-01 Дьюк Юниверсити Генетически кодируемые внутренне неупорядоченные полимеры-"невидимки" для доставки и способы их применения
JP6918365B2 (ja) 2015-08-19 2021-08-11 プレジデント アンド フェローズ オブ ハーバード カレッジ 脂質化ｐｓａ組成物および方法
US11752213B2 (en) 2015-12-21 2023-09-12 Duke University Surfaces having reduced non-specific binding and antigenicity
WO2017112826A2 (en) 2015-12-21 2017-06-29 Duke University Polymer conjugates having reduced antigenicity and methods of using the same
US11246924B2 (en) 2016-04-01 2022-02-15 Duke University Alpha-helical peptide nanofibers as a self-adjuvanting vaccine platform
TWI841843B (zh) 2016-05-03 2024-05-11 瑞士商Ｂｖｗ控股公司 多相凝膠
WO2017210476A1 (en) 2016-06-01 2017-12-07 Duke University Nonfouling biosensors
US11491181B2 (en) 2016-07-15 2022-11-08 President And Fellows Of Harvard College Glycolipid compositions and methods of use
WO2018053201A1 (en) 2016-09-14 2018-03-22 Duke University Triblock polypeptide-based nanoparticles for the delivery of hydrophilic drugs
JP2020500150A (ja) 2016-09-23 2020-01-09 デューク ユニバーシティ 下限臨界溶液温度挙動を有する非反復かつ非構造的ポリペプチド
WO2018132732A1 (en) 2017-01-12 2018-07-19 Duke University Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly
WO2018165194A1 (en) * 2017-03-06 2018-09-13 University Of Washington Engineered cells and agent compositions for therapeutic agent delivery and treatments using same
US20200405881A1 (en) * 2017-03-06 2020-12-31 University Of Washington Cell based methods and compositions for therapeutic agent delivery and treatments using same
WO2018213320A1 (en) 2017-05-15 2018-11-22 Duke University Recombinant production of hybrid lipid-biopolymer materials that self-assemble and encapsulate agents
WO2019006374A1 (en) 2017-06-30 2019-01-03 Duke University ORDER AND DISORDER AS A DESIGN PRINCIPLE FOR STIMULI-SENSITIVE BIOPOLYMER NETWORKS
WO2019147954A1 (en) 2018-01-26 2019-08-01 Duke University Albumin binding peptide-drug (aibiped) conjugates and methods of making and using same
WO2019178288A2 (en) * 2018-03-13 2019-09-19 The Regents Of The University Of California Virus-like nanocapsid for oral delivery of insulin
US11857634B2 (en) * 2018-04-20 2024-01-02 University of Pittsburgh—of the Commonwealth System of Higher Education Cationic amphiphilic polymers for codelivery of hydrophobic agents and nucleic acids
EP3788343B1 (de) 2018-04-30 2024-03-27 Duke University Auf stimuli reagierende plattform zur abgabe von auf peg-like-polymer basierendem arzneimittel
US11649275B2 (en) 2018-08-02 2023-05-16 Duke University Dual agonist fusion proteins
US12594347B2 (en) 2018-09-07 2026-04-07 Duke University Nanoparticulate drug delivery systems
US11512314B2 (en) 2019-07-12 2022-11-29 Duke University Amphiphilic polynucleotides
US12290603B2 (en) 2019-09-27 2025-05-06 Duke University Tabletization of peptide self-assemblies and methods of making and using the same
WO2022271183A1 (en) * 2021-06-25 2022-12-29 Allexcel Inc. Self-assembling amphphlic polymers as anti-covid-19 agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2226299A1 (en) * 1995-08-11 1997-02-27 Dendritech, Inc. Hyper comb-branched polymer conjugates
WO1998001228A2 (en) * 1996-07-08 1998-01-15 Corning Incorporated Rayleigh-breakup atomizing devices and methods of making rayleigh-breakup atomizing devices
ES2317657T3 (es) * 1996-09-19 2009-04-16 The Regents Of The University Of Michigan Polimeros que contienen polisacaridos tales como alginatos o alginatos modificados.
DE19706667A1 (de) * 1997-02-20 1998-08-27 Merck Patent Gmbh Knochenersatzmaterial mit einer Oberflächenbelegung mit Peptiden mit RGD-Aminosäuresequenz
DE69920198T2 (de) * 1998-04-13 2005-09-22 Massachusetts Institute Of Technology, Cambridge Kamm-polymere zur regelung der zelloberflächenwechselwirkung

Also Published As

Publication number Publication date
JP2002511496A (ja) 2002-04-16
AU3556499A (en) 1999-11-01
US6150459A (en) 2000-11-21
US6399700B2 (en) 2002-06-04
CA2328436A1 (en) 1999-10-21
CA2328436C (en) 2008-08-05
US20010027237A1 (en) 2001-10-04
EP1071467B1 (de) 2004-09-15
US6207749B1 (en) 2001-03-27
AU752942B2 (en) 2002-10-03
WO1999052560A1 (en) 1999-10-21
DE69920198D1 (de) 2004-10-21
DE69920198T2 (de) 2005-09-22
EP1071467A1 (de) 2001-01-31

Similar Documents

Publication Publication Date Title
ATE275977T1 (de) Kamm-polymere zur regelung der zelloberflächenwechselwirkung
DE69028011D1 (de) Verlängerte Wirkstoffabgabe von kleinen, wasserlöslichen Molekülen
AU4646397A (en) Polymeric membranes and polymer articles having hydrophilic surface and method for their preparation
Moroni et al. Polymer brush coatings regulating cell behavior: Passive interfaces turn into active
DE60202866D1 (de) Beschichtungen vom typ "bottle-brush" mit verwirbelten polymeren
WO2000004078A8 (en) Method for providing coated moulded polymeric articles
ES2144419T3 (es) Revestimientos polimericos de superficies.
EP1577670A3 (de) Latent-reaktive polymere mit biologisch aktiven gruppen
EP0814097A3 (de) Verfahren zur Herstellung von thermoplastischen Harzen aus Telechelen, verzweigten und sternförmigen Polymeren
NO980981D0 (no) Fremgangsmåte til fremstilling av antimikrobielle plaststoffer
BR0014417A (pt) Processo para preparação de uma mistura polimérica dispersada em água, mistura polimérica dispersada em água, composição para preparação de um revestimento resistente à água, e, artigo revestido resistente à água
DK0991701T3 (da) Hydrofilt overtræk og fremgangsmåde til fremstilling deraf
NZ504119A (en) Water dispersible polymeric compositions
NZ507922A (en) Process for microgel preparation having a crosslinked polymeric core and a multiplicity of appended polymeric arms
SI0821660T2 (sl) Postopek za konzerviranje mineralnega oblikovanca
ATE304567T1 (de) Bioabbaubare blockcopolymere mit modifizierbarer oberfläche
ATE323731T1 (de) Abbaubare, auf polydioxanon basierende materialien
CA2446502A1 (en) High capacity assay platforms
ATE219502T1 (de) Polymere materialien mit zellproliferationsbegünstigenden eigenschaften
MX9100698A (es) Polimero injertado con grupo funcional de isocianato y proceso para su preparacion
Loh Plasma surface modification for biomedical applications
US20100285086A1 (en) Biomimetic Extracellular Matrices
Dubnikova et al. Influence of Characteristics of Initial Components and Structural Homogeneity of Compositions on Plastic Properties of Polymerization-Filled High Density Polyethylene
AU3954497A (en) Support with super-absorbent material, method for the preparation thereof and use
ES2154242A1 (es) Nuevos sistemas polimericos biocompatibles portadores de triflusal o htb.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties